Using Quality Improvement and Implementation Science to Improve Care in Pediatric Dermatology
In this bonus episode of PeDRA Pearls, Carrie Coughlin, MD, MPHS, is joined by a panel of experts to explore how quality improvement and implementation science can help clinicians translate evidence into better, more sustainable care in pediatric dermatology. Through practical examples, Larry Eichenfield, MD, Joanna Tu, MD, and Enyo Ablordeppey, MD, MPH, discuss patient safety, dissemination, implementation and de-implementation, and strategies to identify barriers, measure outcomes, and support lasting change. Listeners will gain ideas for launching projects at any scale—from focused improvements within a clinic to broader system-wide initiatives—and for adapting solutions to their local context.
Through a special collaboration, PeDRA and Lilly have released a new funding opportunity to support healthcare improvement (HCI) initiatives related to adolescent atopic dermatitis (AD). With an application deadline of September 30, 2026, this new program may fund as many as two projects, each with a budget of up to $450,000. Learn more and apply.
Keywords: Implementation Science, Quality Improvement, Patient Safety, Outcome Measures
This program was developed independently by PeDRA with support from Lilly Global Medical Affairs.
Key Definitions
Program Faculty
Dr. Coughlin has no disclosures relevant to this discussion.
Dr. Tu has no disclosures relevant to this discussion.
Dr. Eichenfield has no disclosures relevant to this discussion.
Dr. Ablordeppey has no disclosures relevant to this discussion.
